| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.28 | 0.03 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.04 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.04 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |